Correlation Between Elevation Oncology and Tarsus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Elevation Oncology and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Tarsus Pharmaceuticals.

Diversification Opportunities for Elevation Oncology and Tarsus Pharmaceuticals

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Elevation and Tarsus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Elevation Oncology and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Elevation Oncology is expected to generate 3.68 times less return on investment than Tarsus Pharmaceuticals. In addition to that, Elevation Oncology is 1.67 times more volatile than Tarsus Pharmaceuticals. It trades about 0.04 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.25 per unit of volatility. If you would invest  3,900  in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  740.00  from holding Tarsus Pharmaceuticals or generate 18.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Tarsus Pharmaceuticals

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Elevation Oncology and Tarsus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Tarsus Pharmaceuticals

The main advantage of trading using opposite Elevation Oncology and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.
The idea behind Elevation Oncology and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like